Loading...
Upcoming Cell And Gene Therapy Milestones Are Expected To Transform Long Term Royalty Prospects
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
-64.5%7D
3.4%1Y
-64.5%7D
3.4%You can edit this narrative until Dec 12 2:05 PM. Then, changes will post as Updates.